APSR2026-1043

Yes
Late-Breaking
Submitted
Poster Presentation
 
AP12-023
P100
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1230469-46904-APSR26_ILD_Poster_YANG Lin_432554.pdf
Format: PDF Only
16. Interstitial Lung Disease
5

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Lin Yang * Chinese Center for Disease Control and Prevention National Center for Chronic and Noncommunicable Disease Control and Prevention Beijing China
Zifang Zhou - Chinese Center for Disease Control and Prevention National Center for Chronic and Noncommunicable Disease Control and Prevention Beijing China
Chengzhong Xu - Yichang Center for Disease Control and Prevention Yichang China
Chi Hu - Yichang Center for Disease Control and Prevention Yichang China
Peng Yin - Chinese Center for Disease Control and Prevention National Center for Chronic and Noncommunicable Disease Control and Prevention Beijing China
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
Lin
Yang
18903093711@163.com
+8618903093711
Under 30
China
Original Research
All-cause and cause-specific mortality in incident interstitial lung disease: a seven-year population-based cohort study from Yichang, China
Maximum 25 words
Abstract Content
Population-based data on cause-specific mortality in interstitial lung disease (ILD), particularly in China, remain limited. This study aims to investigate mortality from chronic respiratory disease, cardiovascular disease (CVD), and cancer among incident ILD patients.
In this population-based cohort study, ILD cases were identified from the Yichang Health and Medical Big Data Center, a regional platform covering all levels of healthcare institutions with integrated outpatient, inpatient, and mortality data. ILD records between 1 January 2018 and 31 December 2024 were identified, using 2015-2017 as a washout period. Patients were followed until death or 11 September 2025, whichever occurred first. ILD subtypes were classified as idiopathic, secondary, other secondary, or multi-subtypes. Age was categorized as <50, 50–59, 60–69, 70–79, and ≥80 years. Causes of death were classified by International Classification of Diseases, 10th (chronic respiratory disease, J30–J99; CVD, I00–I99; cancer, C00–C99). Cox proportional hazards regression models were used to examine the associations of sex, age group, and ILD subtypes with all-cause and cause-specific mortality, with mutual adjustment.
Among 53,504 incident ILD, mean age was 61.2 years and 46.0% were females. During a mean follow-up of 2.64 years, 5,522 deaths were recorded, including 1,949 from cancer, 1,343 from CVD and 1,338 from chronic respiratory disease. Male was associated with increased all cause mortality (HR 1.69, 95% CI 1.59–1.78). Using secondary ILD as reference, idiopathic ILD (HR 2.07, 95% CI 1.95–2.19), multi ILD (HR 2.31, 95% CI 1.91–2.79), and other secondary ILD (HR 1.48, 95% CI 1.32–1.65) were associated with higher mortality. More pronounced disparities were observed for chronic respiratory disease death with male (HR 2.33, 95% CI 2.05–2.65) and idiopathic ILD (HR 4.20, 95% CI 3.71–4.75). Cancer showed modest variation across ILD subtypes (idiopathic ILD, HR 1.46, 95% 1.32–1.61).
Male, older age, and idiopathic ILD subtypes were associated with higher mortality. Prevention efforts should prioritize cancer screening in ILD patients, cardiovascular risk control especially in elderly patients, and respiratory monitoring in those with idiopathic ILD.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Interstitial lung disease, Cause-specific mortality, Cohort study
maximum 3 keywords and no abbreviations, separated by commas
 
364